The potential for traditional Chinese therapy in treating sleep disorders caused by COVID-19 through the cholinergic anti-inflammatory pathway.

Xie, Xiaoxia; Zhang, Nana; Fu, Jingya; Wang, Zhenzhi; Ye, Zirun; Liu, Zhijun

Xie, Xiaoxia; Zhang, Nana; Fu, Jingya; Wang, Zhenzhi; Ye, Zirun; Liu, Zhijun.

Afiliação

Xie X; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang N; Shaanxi University of Chinese Medicine, Xian yang, China.
Fu J; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wang Z; National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ye Z; Shaanxi Provincial Center for Regenerative Medicine and Surgical Engineering, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Liu Z; Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Front Pharmacol ; 13: 1009527, 2022.

Article em En | MEDLINE | ID: mdl-36299906

Palavras-chave

cholinergic anti-inflammatory pathway; coronavirus disease 2019; cytokine storms; sleep disorders; traditional Chinese therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China